Medicinal Chemistry
DOI: 10.1007/3-540-06873-2_13
|View full text |Cite
|
Sign up to set email alerts
|

Design of bioactive compounds

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
5
0

Publication Types

Select...
3
1

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(5 citation statements)
references
References 72 publications
0
5
0
Order By: Relevance
“…These are highly selective for the enzyme of mammals (rat) on the (Harms and Nauta, 1960 one hand and bacteria on the other (Fig. 18) (Hitchings, 1964;Ariens and Simonis, 1974). In conclusion, the accessory binding sites next to the active site on enzymes of different origin apparently can differ.…”
Section: Selectivity In Actionmentioning
confidence: 96%
See 1 more Smart Citation
“…These are highly selective for the enzyme of mammals (rat) on the (Harms and Nauta, 1960 one hand and bacteria on the other (Fig. 18) (Hitchings, 1964;Ariens and Simonis, 1974). In conclusion, the accessory binding sites next to the active site on enzymes of different origin apparently can differ.…”
Section: Selectivity In Actionmentioning
confidence: 96%
“…In small agonist molecules, a differentiation is usually difficult to see between the groups in the molecule primarily involved in the receptor binding, the haptophore, and the groups primarily involved in the receptor activation, the actophore. Groups, especially those involved in pharmacon metabolism and pharmacon transport, are more easily recognizable (Ariens and Simonis, 1974;Ariens, 1971b). In larger bioactive molecules, especially polypeptides, programming for various aspects of the function may be localized in different amino acid sequences, as shown schematically in Fig.…”
Section: Structure and Actionmentioning
confidence: 99%
“…However, low selectivity in the toxicity of traditional cationic surfactants may restrict their application, particularly with respect to therapeutic purposes. Side effects due to the persistence of biologically active compounds may be reduced through the design of analogs containing hydrolyzable bonds (2,6). This strategy was previously applied to cationic surfactants by Bodor et al (7) with a series of esters between quaternized a-aminoalcohols and fatty acids which were termed soft antimicrobial agents.…”
Section: Downloaded Frommentioning
confidence: 99%
“…0095-2338/82/1622-0207S01. 25/0 (1) The ability of a chemical compound to exert pharmacological action is determined by its capacity to bind complementarily and interact with the functional chemical structure in the living organism, i.e., the "receptor".…”
Section: Main Prerequisitesmentioning
confidence: 99%